News
1 October 2026
Fonko Strengthens Indonesia’s Oncology Industry Capacity
JAKARTA — PT Fonko International Pharmaceuticals has recorded several key milestones in the development of oncology drug manufacturing in Indonesia. These achievements include securing European Union Good Manufacturing Practice (EU GMP) certification in 2025, developing a range of "first copy" products for cancer therapy, and obtaining halal certification for its…
25 September 2026
Consistently Maintaining Halal Standards, Dexa Group Wins IHYA 2026
TANGERANG — PT Ferron Par Pharmaceuticals, a member of Dexa Group, has won the 2026 Indonesia Halal Industry Award (IHYA) from the Ministry of Industry of the Republic of Indonesia in the Large Industrial Enterprise Category, Subcategory of Best Pharmaceuticals and Traditional Medicines. This award recognizes Dexa Group’s consistency in…
24 September 2026
From Medications to Facilities, Ferron Strengthens Support for Cancer Patients
JAKARTA — Indonesia recorded 474,083 new cases and 283,299 deaths due to cancer, according to 2024 Global Cancer Observatory (GLOBOCAN) data. This situation underscores the critical role of Ferron Par Pharmaceuticals in expanding its support for cancer patients—from delivering access to medications to strengthening chemotherapy support facilities through the provision…
18 March 2023
Dexa Group Wins Public Relations Indonesia Awards 2023
Dexa Group Wins Public Relations Indonesia Awards 2023 After going through a gradual judging process and presenting proposals, Dexa Group's Corporate Communications is considered to have a significant and positive impact on Public Relations (PR) performance throughout 2022. For this achievement, Dexa Group has won the highest award at the…
6 March 2023
Dexa Group Wins the Indonesia Corporate Public Relations Award for the 5th time
Dexa Group was awarded The Best Indonesia Public Relations in the Health Sector by the Indonesia Corporate Public Relation Awards (IPRA) 2023. Dexa Group has won the IPRA Award for the fifth time since 2018. With the theme “Winning Economic Growth Through Consistent Collaboration", IPRA 2023 is being held to…
16 January 2023
BPOM and Dexa Group Collaborate to Educate the Public on Good Manufacturing Practice
Domestic pharmaceutical industry with international standard, Dexa Group participated in Expo of Food and Drug Life Cycle Product Supervision held by The Indonesian National Agency of Drug and Food Control (Badan POM). This event is an educational event from Badan POM as the regulator and the pharmaceutical and food industry…
16 December 2022
Dexa Group’s CEO Named Indonesia Most Acclaimed CEO 2022
For his leadership that has allowed the company to adapt successfully, make breakthroughs, and continue to make developments to provide a positive stimulant to the economy in Indonesia, Dexa Group CEO Mr. Ferry Soetikno was awarded the Indonesia Most Acclaimed CEO 2022 in the pharmaceutical category from WartaEkonomi.co. id. Indonesia…
12 December 2022
Committed to Accelerating the Halal Industry, Dexa Group Achieved Indonesia Halal Industry Awards 2022
As a pioneer in the implementation of research for the Indonesia Indigenous Modern Medicine (OMAI) products certified by the Halal Product Assurance System, Dexa Group has achieved the Indonesia Halal Industry Award (IHYA) 2022 for the Best Halal Innovation category. The award held by the Ministry of Industry of the…
16 November 2022
Figures of Indonesia Indigenous Modern Medicine Receive Honorary Title of Adjunct Professorship from Atma Jaya Catholic University
Dr. Raymond Rubianto Tjandrawinata, a leading figure in Indonesia Indigenous Modern Medicine (OMAI), was awarded the honorary title of Adjunct Professor in Pharmaceutical Biotechnology by the Indonesian Catholic University (Unika) Atma Jaya Jakarta. Dr. Raymond Rubianto Tjandrawinata has demonstrated a scientific discovery and contribution to the advancement of pharmaceutical biotechnology,…
9 November 2022
Dexa Group Leader’s Public Lecture at Sanata Dharma University: Building Independence as a Dexa Group Contribution
Mr. Ferry Soetikno, the leader of the Dexa Group, served as a speaker during the Sanata Dharma University Yogyakarta Public Lecture. During his guest lecture, Mr. Ferry covered two subjects for hundreds of University of Sanata Dharma students and graduates: the introduction of Dexa Medica and the independence of pharmaceuticals…